Behavioral changes in rats with focal cerebral ischemia after directional transplantation of bone marrow mesenchymal stem cells

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 12, Issue 3, 2008, Pages 578-580

  Ma, Xue Ling ^a   Wang, Xin Rui ^b   Jiang, Xin Mei ^a   Chen, Bai Zhu ^c   Li, Xia ^a   Liu, Kang Ding ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; HERMES ANTIGEN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BEHAVIOR CHANGE; BRAIN ISCHEMIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FLOW CYTOMETRY; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MENTAL FUNCTION; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE REGENERATION; NEUROLOGIC DISEASE; NONHUMAN; RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 40949104439     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411): 143-147
2. Noth U, Osyczka AM, Tuli R, et al. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002;20(5):1060-1069
3. Li YM, Schilling T, Benisch P, et al. Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun 2007;363(1):209-215
4. Longa Z, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery: without craniotomy in rats. Stroke 1989;20(1):84-91
5. Hua Y, Schallert T, Keep RF, et al. Behavioral tests after intracerebral hemorrhage in the rat. Stroke 2002;33(10):2478-2484
6. Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986;17(3):472-476
7. Majumdar MK, Thiede MA, Mosca JD, et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998;176(1):57-66
8. Lin JH, Lei SM, Kang DZ, et al. Role of bone marrow stromal cells on rat spinal cord injury by vein transplantation. Zhonghua Guke Zazhi 2005;25(9):556-559
9. Iihoshi S, Honmou O, Houkin K, et al. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 2004;1007(1-2):1-9
10. Wen JM, Ma XL, Liu KD. Advance of mesenchymal stem cells in the therapy of cerebral infarction. Wujing Yixue 2006;17(11):845-846
11. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004;95(1):9-20
12. Simpson D, Liu H, Fan TM, et al. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 2007;25(9):2350-2357
13. Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001;32 (4):1005-1011